PROJECT

Development of binary protein drugs with antimicrobial and anti-inflammatory activity for the treatment of Bovine Respiratory Syndrome.

  • Start date: 01/09/2023

  • End date: 31/08/2026

  • Project Code: A5146_14242

  • Acronym: BINARYDRUG

PROJECT TYPE

  • Projectes R+D Plurianyals

Program

Responsible

SHARE

The general objective of the BINARY-DRUG project is to optimize the formulation of MHAP antimicrobial protein and endow it with anti-inflammatory functions to stop not only BRD pathogens dissemination but also to rescue animals from BRD inflammatory process.

ENTITATS FINANÇADORES

Convocation

  • G.Conocimiento - Proy I+D orientados 2022 - BINARYDRUG
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.